Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 BIO-TECHNEQiagenbluebird bioAdaptive BiotechnologiesNeurocrine Biosciences
SymbolNASDAQ:TECHNYSE:QGENNASDAQ:BLUENASDAQ:ADPTNASDAQ:NBIX
Price Information
Current Price$197.32$33.79$106.14$38.95$101.58
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$204.80$42.40$153.7079$43.00$106.5556
% Upside from Price Target3.79% upside25.48% upside44.82% upside10.40% upside4.90% upside
Trade Information
Market Cap$7.58 billion$7.67 billion$5.78 billion$5.16 billion$9.27 billion
Beta1.210.882.28N/A1.26
Average Volume168,910907,175568,138365,040581,949
Sales & Book Value
Annual Revenue$714.01 million$1.50 billion$54.58 millionN/A$451.24 million
Price / Sales10.475.07107.48N/A20.62
Cashflow$5.8849 per share$2.4397 per shareN/AN/A$0.5207 per share
Price / Cash33.5313.85N/AN/A195.08
Book Value$30.78 per share$11.69 per share$34.47 per shareN/A$5.30 per share
Price / Book6.412.893.08N/A19.17
Profitability
Net Income$96.07 million$190.38 million$-555,630,000.00N/A$21.11 million
EPS$3.80$1.34($10.68)N/A$0.22
Trailing P/E Ratio52.0225.22N/A0.00461.68
Forward P/E Ratio38.6921.52N/AN/A30.23
P/E Growth$4.30$2.08N/AN/A$6.02
Net Margins13.45%12.94%-1,158.04%N/A2.98%
Return on Equity (ROE)13.20%12.10%-35.90%N/A0.46%
Return on Assets (ROA)7.98%5.76%-29.91%N/A0.21%
Dividend
Annual Payout$1.28N/AN/AN/AN/A
Dividend Yield0.65%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio33.68%N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.42%0.54%0.11%N/A0.96%
Current Ratio4.05%1.77%8.02%5.91%7.44%
Quick Ratio3.15%1.59%8.02%5.80%7.32%
Ownership Information
Institutional Ownership Percentage91.65%62.10%N/A62.83%96.10%
Insider Ownership Percentage4.20%9.00%3.00%34.70%4.30%
Miscellaneous
Employees2,2504,952764346585
Shares Outstanding37.89 million225.51 million55.27 million124.29 million91.58 million
Next Earnings Date10/29/2019 (Estimated)11/4/2019 (Estimated)11/7/2019 (Estimated)11/12/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable
 BIO-TECHNEQiagenbluebird bioAdaptive BiotechnologiesNeurocrine Biosciences

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel